Objective:To analyze the application value of artificial intelligence(AI)in the comprehensive service pathway for rational clinical use of western medicines.Methods:A sample of 73 patients undergoing western medicine ...Objective:To analyze the application value of artificial intelligence(AI)in the comprehensive service pathway for rational clinical use of western medicines.Methods:A sample of 73 patients undergoing western medicine treatment from December 2024 to March 2025 was selected and divided into groups by lottery.Group A received AI-assisted management for rational clinical use of western medicines,while Group B received conventional management.Thirty-six patients taking oral western medicines were included in Group B.Results:Group A outperformed Group B in terms of the irrationality rate of western medicine usage,drug management scores,adverse reaction rates,complaint rates,and satisfaction levels,with p<0.05.Conclusion:AI-assisted rational clinical use of western medicines enhances drug management quality,reduces the irrationality rate of medication usage,and decreases complaint rates related to western medicine usage.展开更多
Stroke is the second leading cause of disability and mortality worldwide,imposing a substantial socioeconomic burden on individuals and healthcare systems.Annually,approximately 14 million people experience stroke,wit...Stroke is the second leading cause of disability and mortality worldwide,imposing a substantial socioeconomic burden on individuals and healthcare systems.Annually,approximately 14 million people experience stroke,with ischemic stroke comprising nearly 85%of cases,of which 10%to 20%involve large vessel occlusions.Currently,recombinant tissue plasminogen activator(tPA)remains the only approved pharmacological intervention.However,its utility is limited due to a narrow therapeutic window and low recanalization rates,making it applicable to only a minority of patients.Therefore,there is an urgent need for novel therapeutic strategies,including pharmacological advancements and combinatory treatments.Small-molecule natural medicines,particularly those derived from traditional Chinese herbs,have demonstrated significant therapeutic potential in ischemic stroke management.These compounds exert multiple neuroprotective effects,such as antioxidation,anti-inflammatory action,and inhibition of apoptosis,all of which are critical in mitigating stroke-induced cerebral damage.This review comprehensively examines the pathophysiology of acute ischemic stroke(AIS)and highlights the recent progress in the development of small-molecule natural medicines as promising therapeutic agents for cerebral ischemic stroke.展开更多
Editorial Policy Asian Journal of Traditional Medicines is an international journal devoted to the advancement of research on traditional medicines.The followed areas are covered:scientific and technological developme...Editorial Policy Asian Journal of Traditional Medicines is an international journal devoted to the advancement of research on traditional medicines.The followed areas are covered:scientific and technological developments and research achievements in the fields of traditional medicine resources,medicinal material processing,pharmacognosy,natural medicinal chemistry,quality control,pharmacology,pharmacy,and clinical efficacy.It has columns for monographs,reviews,full research articles,short articles,newsletters and clinical case reports of traditional Chinese medicines.展开更多
Editorial Policy Asian Journal of Traditional Medicines is an international journal devoted to the advancement of research on traditional medicines.The followed areas are covered:scientific and technological developme...Editorial Policy Asian Journal of Traditional Medicines is an international journal devoted to the advancement of research on traditional medicines.The followed areas are covered:scientific and technological developments and research achievements in the fields of traditional medicine resources,medicinal material processing,pharmacognosy,natural medicinal chemistry,quality control,pharmacology,pharmacy,and clinical efficacy.It has columns for monographs,reviews,full research articles,short articles,newsletters and clinical case reports of traditional Chinese medicines.展开更多
Editorial Policy Asian Journal of Traditional Medicines is an international journal devoted to the advancement of research on traditional medicines.The followed areas are covered:scientific and technological developme...Editorial Policy Asian Journal of Traditional Medicines is an international journal devoted to the advancement of research on traditional medicines.The followed areas are covered:scientific and technological developments and research achievements in the fields of traditional medicine resources,medicinal material processing,pharmacognosy,natural medicinal chemistry,quality control,pharmacology,pharmacy,and clinical efficacy.It has columns for monographs,reviews,full research articles,short articles,newsletters and clinical case reports of traditional Chinese medicines.展开更多
Non-alcoholic fatty liver disease(NAFLD)is a metabolic disease characterized by abnormal deposition of lipid in hepatocytes.If not intervened in time,NAFLD may develop into liver fibrosis or liver cancer,and ultimatel...Non-alcoholic fatty liver disease(NAFLD)is a metabolic disease characterized by abnormal deposition of lipid in hepatocytes.If not intervened in time,NAFLD may develop into liver fibrosis or liver cancer,and ultimately threatening life.NAFLD has complicated etiology and pathogenesis,and there are no effective therapeutic means and specific drugs.Currently,insulin sensitizers,lipid-lowering agents and hepatoprotective agents are often used for clinical intervention,but these drugs have obvious side effects,and their effectiveness and safety need to be further confirmed.Adenosine monophosphate(AMP)-activated protein kinase(AMPK)plays a central role in maintaining energy homeostasis.Activated AMPK can enhance lipid degradation,alleviate insulin resistance(IR),suppress oxidative stress and inflammatory response,and regulate autophagy,thereby alleviating NAFLD.Natural herbal medicines have received extensive attention recently because of their regulatory effects on AMPK and low side effects.In this article,we reviewed the biologically active natural herbal medicines(such as natural herbal medicine formulas,extracts,polysaccharides,andmonomers)that reported in recent years to treatNAFLD via regulating AMPK,which can serve as a foundation for subsequent development of candidate drugs for NAFLD.展开更多
A novel low molecular weight compound polysaccharide(LMW-CPS) was identified from a specific combination of Chinese herb ingredients.The monosaccharide composition of LMW-CPS was consisted of single arabinose,which ha...A novel low molecular weight compound polysaccharide(LMW-CPS) was identified from a specific combination of Chinese herb ingredients.The monosaccharide composition of LMW-CPS was consisted of single arabinose,which had an α-L-furanose configuration with an average molecular weight of 2.06 kDa.NMR spectra and monosaccharide constitution analyses revealed that it had a backbone of→5)-α-L-Araf-(1→with α-L-Araf(1→as the terminal residue.In vitro experiments found that it could lead to apoptosis and inhibit hepatocellular carcinoma cell proliferation by arresting them in the S phase.In vivo experiments showed that it protected immune organs such as the thymus and spleen,enhanced immune cell activities,stimulated cytokine release,augmented the abundance of CD8,CD3,CD4,and CD 19 positive lymphocytes,and markedly impeded solid hepatocellular carcinoma progression in mice.Hematoxylin and eosin staining and cell cycle examination also indicated that LMW-CPS arrested hepatocellular carcinoma cells at the S phase to induce apoptosis.These findings indicated its promising potential for the treatment of hepatocellular carcinoma.展开更多
Natural medicines(NMs)demonstrate distinct advantages in the clinical management of chronic diseases.Recent years have seen growing recognition of the gut microbiota's role in the efficacy and synergy of NMs,provi...Natural medicines(NMs)demonstrate distinct advantages in the clinical management of chronic diseases.Recent years have seen growing recognition of the gut microbiota's role in the efficacy and synergy of NMs,providing new impetus for elucidating the material basis and mechanisms of NMs and their path toward modernization.A fundamental question that has emerged is how NM-microbiota interactions integrate into the multi-target holistic mechanisms of NMs,the answer to which may also illuminate new avenues for drug discovery.Metabolic regulation via small-molecule metabolites has been increasingly implicated in host-microbe interaction.This review presents an integral metabolic perspective on NMs-microbiota interaction in host health and disease.It highlights the emerging understanding of gut microbiota-related metabolic signals implicated in NM components'local and systemic actions.Additionally,it discusses key issues and prospects related to drug development and the translational study of NMs.展开更多
Natural products(NPs)derived from plants,microbes,and marine organisms have historically been a cornerstone of pharmacotherapy,accounting for approximately 35%of FDA-approved small-molecule drugs since 19811.These com...Natural products(NPs)derived from plants,microbes,and marine organisms have historically been a cornerstone of pharmacotherapy,accounting for approximately 35%of FDA-approved small-molecule drugs since 19811.These compounds have been instrumental in drug discovery,particularly for cancer and infectious diseases,as well as in other therapeutic areas such as cardiovascular diseases(e.g.,statins)and multiple sclerosis(e.g.,fingolimod).展开更多
Background: The availability of essential medicines and medical supplies is crucial for effectively delivering healthcare services. In Zambia, the Logistics Management Information System (LMIS) is a key tool for manag...Background: The availability of essential medicines and medical supplies is crucial for effectively delivering healthcare services. In Zambia, the Logistics Management Information System (LMIS) is a key tool for managing the supply chain of these commodities. This study aimed to evaluate the effectiveness of LMIS in ensuring the availability of essential medicines and medical supplies in public hospitals in the Copperbelt Province of Zambia. Materials and Methods: From February to April 2022, a cross-sectional study was conducted in 12 public hospitals across the Copperbelt Province. Data were collected using structured questionnaires, checklists, and stock control cards. The study assessed LMIS availability, training, and knowledge among pharmacy personnel, as well as data accuracy, product availability, and order fill rates. Descriptive statistics were used to analyse the data. Results: All surveyed hospitals had LMIS implemented and were using eLMIS as the primary LMIS. Only 47% and 48% of pharmacy personnel received training in eLMIS and Essential Medicines Logistics Improvement Program (EMLIP), respectively. Most personnel demonstrated good knowledge of LMIS, with 77.7% able to log in to eLMIS Facility Edition, 76.6% able to locate stock control cards in the system, and 78.7% able to perform transactions. However, data accuracy from physical and electronic records varied from 0% to 60%, and product availability ranged from 50% to 80%. Order fill rates from Zambia Medicines and Medical Supplies Agency (ZAMMSA) were consistently below 30%. Discrepancies were observed between physical stock counts and eLMIS records. Conclusion: This study found that most hospitals in the Copperbelt Province of Zambia have implemented LMIS use. While LMIS implementation is high in the Copperbelt Province of Zambia, challenges such as low training levels, data inaccuracies, low product availability, and order fill rates persist. Addressing these issues requires a comprehensive approach, including capacity building, data quality improvement, supply chain coordination, and investment in infrastructure and human resources. Strengthening LMIS effectiveness is crucial for improving healthcare delivery and patient outcomes in Zambia.展开更多
Objective To predict the autophagy-related pathogenesis and key diagnostic genes of diabetic kidney disease(DKD)through bioinformatics analysis,and to identify related Chinese medicines.Methods Data from sequencing mi...Objective To predict the autophagy-related pathogenesis and key diagnostic genes of diabetic kidney disease(DKD)through bioinformatics analysis,and to identify related Chinese medicines.Methods Data from sequencing microarrays GSE30528,GSE30529,and GSE1009 in the Gene Expression Omnibus(GEO)were employed.Differentially expressed genes(DEGs)with adjusted P<0.05 from GSE30528 and GSE30529 were identified.Combining these DEGs with the human autophagy gene database,Gene Ontology(GO),Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment analyses,and protein-protein interaction(PPI)network analysis were conducted on the obtained DKD autophagy-related genes.Subsequently,the least absolute shrinkage and selection operator(LASSO)regression and support vector machinerecursive feature elimination(SVM-RFE)algorithms were adopted to select autophagy-related genes.The diagnostic capability of these genes was assessed through analysis with the external validation set from microarray GSE1009,and relevant Chinese medicines were inversely predicted using the SymMap database.Results A total of 2014 DEGs were selected from GSE30528 and GSE30529,leading to the identification of 37 DKD autophagy-related genes.GO analysis indicated 681 biological mechanisms,including autophagy regulation and plasma membrane microdomain activity.KEGG enrichment analysis identified 112 related signaling pathways.PPI network analysis showed a marked enrichment of autophagy-related genes in DKD.Through LASSO regression and SVM-RFE,four core diagnostic genes for autophagy in DKD were identified:protein phosphatase 1 regulatory subunit 15A(PPP1R15A),hypoxia inducible factor 1 alpha subunit(HIF1α),deleted in liver cancer 1(DLC1),and ceroid lipofuscinosis neuronal 3(CLN3).The external validation set demonstrated high diagnostic efficiency for these genes.Finally,146 kinds of potential Chinese medicines were predicted using the SymMap database,with heatclearing and detoxifying medicine and blood-activating and stasis-eliminating medicine accounting for the largest proportion(25/146 and 13/146,respectively).Conclusion This study analyzed and validated bioinformatics sequencing databases to elucidate the potential molecular mechanisms of DKD autophagy and predicted key diagnostic genes,potential therapeutic targets,and related Chinese medicines,laying a solid foundation for clinical research and application.展开更多
Objective:Irrational medicine consumption practices increase the country's health expenditures and raise public health concerns,challenging sustainable development in multiple ways.The objective of this study is t...Objective:Irrational medicine consumption practices increase the country's health expenditures and raise public health concerns,challenging sustainable development in multiple ways.The objective of this study is to identify the key factors influencing irrational medicine consumption and devise a strategic framework to encourage responsible medicine use.Method:A cross-sectional qualitative descriptive design was used.Study data were collected using semi-structured interviews and analysed using thematic analysis to identify the key factors contributing to irrational medicine consumption.Results:Various factors like cyberchondria coupled with health misinformation,inaccessible healthcare,limited product choices,misleading online pharmacies,and infeasible pharmaceutical regulations act as key drivers of irresponsible medicine consumption.The participants recommended enhancing healthcare access,utilizing technology,promoting health literacy,and updating regulations as strategies to improve responsible medicine use.Against this backdrop,the study proposes a double helix model for responsible consumption of medicines through bilateral efforts from both consumers and the health system.Conclusion:Highlighting the importance of responsible consumption,this paper calls health system actors to action to accelerate the efforts to foster responsible consumption of medicines.展开更多
文摘Objective:To analyze the application value of artificial intelligence(AI)in the comprehensive service pathway for rational clinical use of western medicines.Methods:A sample of 73 patients undergoing western medicine treatment from December 2024 to March 2025 was selected and divided into groups by lottery.Group A received AI-assisted management for rational clinical use of western medicines,while Group B received conventional management.Thirty-six patients taking oral western medicines were included in Group B.Results:Group A outperformed Group B in terms of the irrationality rate of western medicine usage,drug management scores,adverse reaction rates,complaint rates,and satisfaction levels,with p<0.05.Conclusion:AI-assisted rational clinical use of western medicines enhances drug management quality,reduces the irrationality rate of medication usage,and decreases complaint rates related to western medicine usage.
基金supported by the National Natural Science Foundation of China(Nos.82174010 and 81973512)。
文摘Stroke is the second leading cause of disability and mortality worldwide,imposing a substantial socioeconomic burden on individuals and healthcare systems.Annually,approximately 14 million people experience stroke,with ischemic stroke comprising nearly 85%of cases,of which 10%to 20%involve large vessel occlusions.Currently,recombinant tissue plasminogen activator(tPA)remains the only approved pharmacological intervention.However,its utility is limited due to a narrow therapeutic window and low recanalization rates,making it applicable to only a minority of patients.Therefore,there is an urgent need for novel therapeutic strategies,including pharmacological advancements and combinatory treatments.Small-molecule natural medicines,particularly those derived from traditional Chinese herbs,have demonstrated significant therapeutic potential in ischemic stroke management.These compounds exert multiple neuroprotective effects,such as antioxidation,anti-inflammatory action,and inhibition of apoptosis,all of which are critical in mitigating stroke-induced cerebral damage.This review comprehensively examines the pathophysiology of acute ischemic stroke(AIS)and highlights the recent progress in the development of small-molecule natural medicines as promising therapeutic agents for cerebral ischemic stroke.
文摘Editorial Policy Asian Journal of Traditional Medicines is an international journal devoted to the advancement of research on traditional medicines.The followed areas are covered:scientific and technological developments and research achievements in the fields of traditional medicine resources,medicinal material processing,pharmacognosy,natural medicinal chemistry,quality control,pharmacology,pharmacy,and clinical efficacy.It has columns for monographs,reviews,full research articles,short articles,newsletters and clinical case reports of traditional Chinese medicines.
文摘Editorial Policy Asian Journal of Traditional Medicines is an international journal devoted to the advancement of research on traditional medicines.The followed areas are covered:scientific and technological developments and research achievements in the fields of traditional medicine resources,medicinal material processing,pharmacognosy,natural medicinal chemistry,quality control,pharmacology,pharmacy,and clinical efficacy.It has columns for monographs,reviews,full research articles,short articles,newsletters and clinical case reports of traditional Chinese medicines.
文摘Editorial Policy Asian Journal of Traditional Medicines is an international journal devoted to the advancement of research on traditional medicines.The followed areas are covered:scientific and technological developments and research achievements in the fields of traditional medicine resources,medicinal material processing,pharmacognosy,natural medicinal chemistry,quality control,pharmacology,pharmacy,and clinical efficacy.It has columns for monographs,reviews,full research articles,short articles,newsletters and clinical case reports of traditional Chinese medicines.
基金funded by the Chongqing Clinical Pharmacy Key Specialties Construction Project,Central Guidance for Local Scientific and Technological Development Special Project of Sichuan Province,China(Grant No.:2023ZYD0283)Natural Science Foundation of Chongqing Municipality,China(Grant No.:CSTB2024NSCQ-MSX1180).
文摘Non-alcoholic fatty liver disease(NAFLD)is a metabolic disease characterized by abnormal deposition of lipid in hepatocytes.If not intervened in time,NAFLD may develop into liver fibrosis or liver cancer,and ultimately threatening life.NAFLD has complicated etiology and pathogenesis,and there are no effective therapeutic means and specific drugs.Currently,insulin sensitizers,lipid-lowering agents and hepatoprotective agents are often used for clinical intervention,but these drugs have obvious side effects,and their effectiveness and safety need to be further confirmed.Adenosine monophosphate(AMP)-activated protein kinase(AMPK)plays a central role in maintaining energy homeostasis.Activated AMPK can enhance lipid degradation,alleviate insulin resistance(IR),suppress oxidative stress and inflammatory response,and regulate autophagy,thereby alleviating NAFLD.Natural herbal medicines have received extensive attention recently because of their regulatory effects on AMPK and low side effects.In this article,we reviewed the biologically active natural herbal medicines(such as natural herbal medicine formulas,extracts,polysaccharides,andmonomers)that reported in recent years to treatNAFLD via regulating AMPK,which can serve as a foundation for subsequent development of candidate drugs for NAFLD.
基金supported by the National Key Research and Development Program of China (2022YFF1100904)the Tianjin Key R&D Program (21YFSNSN00110)+2 种基金the Science and Technology Planning Project of State Administration for Market Regulation (2019MK005, 2020MK010, 2022MK012)Tianjin Administration for Market Regulation (2019-W20)State Criteria for Food Safety (spaq-2020-08, spaq-2020-31, spaq-2021-07, spaq-2022-05)。
文摘A novel low molecular weight compound polysaccharide(LMW-CPS) was identified from a specific combination of Chinese herb ingredients.The monosaccharide composition of LMW-CPS was consisted of single arabinose,which had an α-L-furanose configuration with an average molecular weight of 2.06 kDa.NMR spectra and monosaccharide constitution analyses revealed that it had a backbone of→5)-α-L-Araf-(1→with α-L-Araf(1→as the terminal residue.In vitro experiments found that it could lead to apoptosis and inhibit hepatocellular carcinoma cell proliferation by arresting them in the S phase.In vivo experiments showed that it protected immune organs such as the thymus and spleen,enhanced immune cell activities,stimulated cytokine release,augmented the abundance of CD8,CD3,CD4,and CD 19 positive lymphocytes,and markedly impeded solid hepatocellular carcinoma progression in mice.Hematoxylin and eosin staining and cell cycle examination also indicated that LMW-CPS arrested hepatocellular carcinoma cells at the S phase to induce apoptosis.These findings indicated its promising potential for the treatment of hepatocellular carcinoma.
基金supported by the National Key Research and Development Program of China (No.2021YFA1301300)the Na-tional Natural Science Foundation of China (Nos.82321005 and 82274009)+1 种基金the“Double-first”Discipline Funding of China Pharmaceutical University (No.CPUQNJC22_09)the Natural Science Foundation of Jiangsu Province of China (No.SKLNMZZ202202)。
文摘Natural medicines(NMs)demonstrate distinct advantages in the clinical management of chronic diseases.Recent years have seen growing recognition of the gut microbiota's role in the efficacy and synergy of NMs,providing new impetus for elucidating the material basis and mechanisms of NMs and their path toward modernization.A fundamental question that has emerged is how NM-microbiota interactions integrate into the multi-target holistic mechanisms of NMs,the answer to which may also illuminate new avenues for drug discovery.Metabolic regulation via small-molecule metabolites has been increasingly implicated in host-microbe interaction.This review presents an integral metabolic perspective on NMs-microbiota interaction in host health and disease.It highlights the emerging understanding of gut microbiota-related metabolic signals implicated in NM components'local and systemic actions.Additionally,it discusses key issues and prospects related to drug development and the translational study of NMs.
文摘Natural products(NPs)derived from plants,microbes,and marine organisms have historically been a cornerstone of pharmacotherapy,accounting for approximately 35%of FDA-approved small-molecule drugs since 19811.These compounds have been instrumental in drug discovery,particularly for cancer and infectious diseases,as well as in other therapeutic areas such as cardiovascular diseases(e.g.,statins)and multiple sclerosis(e.g.,fingolimod).
文摘Background: The availability of essential medicines and medical supplies is crucial for effectively delivering healthcare services. In Zambia, the Logistics Management Information System (LMIS) is a key tool for managing the supply chain of these commodities. This study aimed to evaluate the effectiveness of LMIS in ensuring the availability of essential medicines and medical supplies in public hospitals in the Copperbelt Province of Zambia. Materials and Methods: From February to April 2022, a cross-sectional study was conducted in 12 public hospitals across the Copperbelt Province. Data were collected using structured questionnaires, checklists, and stock control cards. The study assessed LMIS availability, training, and knowledge among pharmacy personnel, as well as data accuracy, product availability, and order fill rates. Descriptive statistics were used to analyse the data. Results: All surveyed hospitals had LMIS implemented and were using eLMIS as the primary LMIS. Only 47% and 48% of pharmacy personnel received training in eLMIS and Essential Medicines Logistics Improvement Program (EMLIP), respectively. Most personnel demonstrated good knowledge of LMIS, with 77.7% able to log in to eLMIS Facility Edition, 76.6% able to locate stock control cards in the system, and 78.7% able to perform transactions. However, data accuracy from physical and electronic records varied from 0% to 60%, and product availability ranged from 50% to 80%. Order fill rates from Zambia Medicines and Medical Supplies Agency (ZAMMSA) were consistently below 30%. Discrepancies were observed between physical stock counts and eLMIS records. Conclusion: This study found that most hospitals in the Copperbelt Province of Zambia have implemented LMIS use. While LMIS implementation is high in the Copperbelt Province of Zambia, challenges such as low training levels, data inaccuracies, low product availability, and order fill rates persist. Addressing these issues requires a comprehensive approach, including capacity building, data quality improvement, supply chain coordination, and investment in infrastructure and human resources. Strengthening LMIS effectiveness is crucial for improving healthcare delivery and patient outcomes in Zambia.
基金National Natural Science Foundation of China(82170747),and Shanghai Key Laboratory of Traditional Chinese Clinical Medicine(20DZ2272200).
文摘Objective To predict the autophagy-related pathogenesis and key diagnostic genes of diabetic kidney disease(DKD)through bioinformatics analysis,and to identify related Chinese medicines.Methods Data from sequencing microarrays GSE30528,GSE30529,and GSE1009 in the Gene Expression Omnibus(GEO)were employed.Differentially expressed genes(DEGs)with adjusted P<0.05 from GSE30528 and GSE30529 were identified.Combining these DEGs with the human autophagy gene database,Gene Ontology(GO),Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment analyses,and protein-protein interaction(PPI)network analysis were conducted on the obtained DKD autophagy-related genes.Subsequently,the least absolute shrinkage and selection operator(LASSO)regression and support vector machinerecursive feature elimination(SVM-RFE)algorithms were adopted to select autophagy-related genes.The diagnostic capability of these genes was assessed through analysis with the external validation set from microarray GSE1009,and relevant Chinese medicines were inversely predicted using the SymMap database.Results A total of 2014 DEGs were selected from GSE30528 and GSE30529,leading to the identification of 37 DKD autophagy-related genes.GO analysis indicated 681 biological mechanisms,including autophagy regulation and plasma membrane microdomain activity.KEGG enrichment analysis identified 112 related signaling pathways.PPI network analysis showed a marked enrichment of autophagy-related genes in DKD.Through LASSO regression and SVM-RFE,four core diagnostic genes for autophagy in DKD were identified:protein phosphatase 1 regulatory subunit 15A(PPP1R15A),hypoxia inducible factor 1 alpha subunit(HIF1α),deleted in liver cancer 1(DLC1),and ceroid lipofuscinosis neuronal 3(CLN3).The external validation set demonstrated high diagnostic efficiency for these genes.Finally,146 kinds of potential Chinese medicines were predicted using the SymMap database,with heatclearing and detoxifying medicine and blood-activating and stasis-eliminating medicine accounting for the largest proportion(25/146 and 13/146,respectively).Conclusion This study analyzed and validated bioinformatics sequencing databases to elucidate the potential molecular mechanisms of DKD autophagy and predicted key diagnostic genes,potential therapeutic targets,and related Chinese medicines,laying a solid foundation for clinical research and application.
文摘Objective:Irrational medicine consumption practices increase the country's health expenditures and raise public health concerns,challenging sustainable development in multiple ways.The objective of this study is to identify the key factors influencing irrational medicine consumption and devise a strategic framework to encourage responsible medicine use.Method:A cross-sectional qualitative descriptive design was used.Study data were collected using semi-structured interviews and analysed using thematic analysis to identify the key factors contributing to irrational medicine consumption.Results:Various factors like cyberchondria coupled with health misinformation,inaccessible healthcare,limited product choices,misleading online pharmacies,and infeasible pharmaceutical regulations act as key drivers of irresponsible medicine consumption.The participants recommended enhancing healthcare access,utilizing technology,promoting health literacy,and updating regulations as strategies to improve responsible medicine use.Against this backdrop,the study proposes a double helix model for responsible consumption of medicines through bilateral efforts from both consumers and the health system.Conclusion:Highlighting the importance of responsible consumption,this paper calls health system actors to action to accelerate the efforts to foster responsible consumption of medicines.
